Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Chi Fong is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
09/11/2024 | ROIV | Buy Now | Roivant Sciences | $10.70 | 16.82% | Chi Fong25% | $12 → $12.5 | Maintains | Neutral | Get Alert |
01/02/2024 | ROIV | Buy Now | Roivant Sciences | $10.70 | 12.15% | Chi Fong25% | $11 → $12 | Maintains | Neutral | Get Alert |
10/09/2023 | CCCC | Buy Now | C4 Therapeutics | $2.18 | -8.25% | Chi Fong25% | $5 → $2 | Maintains | Neutral | Get Alert |
06/08/2023 | ROIV | Buy Now | Roivant Sciences | $10.70 | -1.87% | Chi Fong25% | → $10.5 | Initiates | → Neutral | Get Alert |
03/28/2023 | CCCC | Buy Now | C4 Therapeutics | $2.18 | 129.37% | Chi Fong25% | $11 → $5 | Maintains | Neutral | Get Alert |
03/28/2023 | FHTX | Buy Now | Foghorn Therapeutics | $3.97 | 151.89% | Chi Fong25% | → $10 | Initiates | → Buy | Get Alert |
11/23/2021 | CCCC | Buy Now | C4 Therapeutics | $2.18 | 2377.18% | Chi Fong25% | → $54 | Initiates | → Buy | Get Alert |